Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Buckner

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumorsJ C Buckner, P P Peethambaram, W A Smithson, et al.
Investigational New Drugs|August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomasP A Burch, A M Bernath, T L Cascino, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404M D Prados, C Scott, H Sandler, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase II study of amonafide in patients with recurrent gliomaR Levitt, J C Buckner, T L Cascino, et al.
Journal of Neurosurgery|March 1, 1995
Phase II evaluation of recombinant interferon alpha and BCNU in recurrent gliomaJ C Buckner, L D Brown, J W Kugler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade gliomaR P Dinapoli, L D Brown, R M Arusell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group resultsE Galanis, J C Buckner, P A Burch, et al.
Journal of the National Cancer Institute|August 16, 2001
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiformeJ S Smith, I Tachibana, S M Passe, et al.
International Journal of Oncology|July 31, 1999
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluationC D James, E Galanis, L Frederick, et al.
Journal of Neuro-Oncology|February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent gliomaS V Rajkumar, J M Reid, P J Novotny, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumorsJ C Buckner, P P Peethambaram, W A Smithson, et al.
Investigational New Drugs|August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomasP A Burch, A M Bernath, T L Cascino, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404M D Prados, C Scott, H Sandler, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase II study of amonafide in patients with recurrent gliomaR Levitt, J C Buckner, T L Cascino, et al.
Journal of Neurosurgery|March 1, 1995
Phase II evaluation of recombinant interferon alpha and BCNU in recurrent gliomaJ C Buckner, L D Brown, J W Kugler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade gliomaR P Dinapoli, L D Brown, R M Arusell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group resultsE Galanis, J C Buckner, P A Burch, et al.
Journal of the National Cancer Institute|August 16, 2001
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiformeJ S Smith, I Tachibana, S M Passe, et al.
International Journal of Oncology|July 31, 1999
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluationC D James, E Galanis, L Frederick, et al.
Journal of Neuro-Oncology|February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent gliomaS V Rajkumar, J M Reid, P J Novotny, et al.
Pageof 8